Trademark: 97642362
Word
EPIC
Status Date
Tuesday, May 7, 2024
Filing Date
Friday, October 21, 2022
Published for Opposition
Tuesday, March 12, 2024
40 Contract manufacturing of therapeutic medicinal products, namely, Contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
5 Chemical, biological and biochemical preparations and reagents for the cultivation of human immune cells, in particular T cells, for medical purposes in the treatment of immuno-oncological diseases; Human immune cells, in particular T cells, for medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cells, in particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases
1 human immune cells, in particular T cells, for scientific and medical research
44 Medical services related to the treatment and preparation of human cells; medical services, namely, immune cell therapy; medical services, namely, immune cell modification; medical services, namely, administration of immune cells; medical consulting related to immune cell therapy, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
42 development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
Oct 25, 2022
New Application Entered
Nov 6, 2022
New Application Office Supplied Data Entered
Nov 8, 2022
Teas Voluntary Amendment Received
Jan 5, 2023
Assigned To Lie
Jan 6, 2023
Preliminary/Voluntary Amendment - Entered
Mar 31, 2023
Assigned To Examiner
Apr 10, 2023
Non-Final Action Written
Apr 10, 2023
Non-Final Action E-Mailed
Apr 10, 2023
Notification Of Non-Final Action E-Mailed
Apr 26, 2023
Teas Response To Office Action Received
Apr 26, 2023
Correspondence Received In Law Office
Apr 26, 2023
Teas/Email Correspondence Entered
May 18, 2023
Examiners Amendment -Written
May 18, 2023
Examiners Amendment E-Mailed
May 18, 2023
Notification Of Examiners Amendment E-Mailed
May 18, 2023
Examiner's Amendment Entered
May 18, 2023
Approved For Pub - Principal Register
Jun 23, 2023
On Hold - Electronic Record Review Required
Jun 30, 2023
Electronic Record Review Complete
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Aug 8, 2023
Published For Opposition
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 8, 2023
Notice Of Allowance Cancelled
Nov 8, 2023
Case Returned To Examination
Nov 29, 2023
Previous Allowance Count Withdrawn
Nov 29, 2023
Suspension Letter Written
Nov 29, 2023
Letter Of Suspension E-Mailed
Nov 29, 2023
Notification Of Letter Of Suspension E-Mailed
Jan 15, 2024
Teas Response To Suspension Inquiry Received
Jan 16, 2024
Correspondence Received In Law Office
Jan 16, 2024
Teas/Email Correspondence Entered
Jan 31, 2024
Approved For Pub - Principal Register
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Mar 12, 2024
Published For Opposition
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
May 7, 2024
Noa E-Mailed - Sou Required From Applicant
May 7, 2024
Teas Delete 1(B) Basis Received
Trademark Alertz updated from USPTO on 2030-01-24
